Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael E. Perlman
Michael E. Perlman
Pfizer
Chemistry
Cholesterylester transfer protein
Biochemistry
Lipid digestion
CETP inhibitor
3
Papers
407
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623
2017
Molecular Pharmaceutics
Claire Louise McEvoy
Natalie Trevaskis
Orlagh M. Feeney
Glenn A. Edwards
Michael E. Perlman
Catherine M. Ambler
Christopher John Porter
Show All
Source
Cite
Save
Citations (12)
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623.
2014
European Journal of Pharmaceutics and Biopharmaceutics
Claire Louise McEvoy
Natalie Trevaskis
Glenn A. Edwards
Michael E. Perlman
Catherine M. Ambler
Mary C Mack
Barbara Brockhurst
Christopher John Porter
Show All
Source
Cite
Save
Citations (12)
Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein An Initial Multidose Study of Torcetrapib
2004
Arteriosclerosis, Thrombosis, and Vascular Biology
Ronald W. Clark
Tamara Sutfin
Roger Benjamin Ruggeri
Ann T. Willauer
Eliot Sugarman
George Tetteh Magnus-Aryitey
Patricia G. Cosgrove
Thomas Sand
Ronald Thure Wester
John A. Williams
Michael E. Perlman
Mark J. Bamberger
Show All
Source
Cite
Save
Citations (383)
1